How ESR and CRP Blood Tests Help Confirm Polymyalgia Rheumatica Before Treatment

The kettle is the tell. A woman in her early seventies, who gardened through last autumn without complaint, now needs both hands and a wince to lift it. Getting out of bed has become a slow roll to the edge and a pause. Her shoulders and hips ache on both sides, worst first thing, easing a little by lunch. Her doctor listens, examines her, and orders polymyalgia rheumatica blood tests: ESR and CRP, plus a handful of others on the same form.

That form raises an obvious question. If polymyalgia rheumatica (PMR) is diagnosed mainly from the story and the examination, what are the blood tests for? The honest answer is that they do three jobs at once. They show whether the body is inflamed, they help rule out conditions that imitate PMR, and they draw a starting line before any medicine is taken.

This explainer walks through what those two inflammation markers measure, what results commonly look like, why a normal result is not the end of the conversation, and which symptoms should never wait for a laboratory.

Polymyalgia rheumatica blood tests: why ESR and CRP come first

Polymyalgia rheumatica is an inflammatory condition that causes pain and stiffness around the shoulders, neck and hips, almost always in people over 50. There is no single test that proves it. That absence shapes everything that follows, because a clinician cannot send a sample to a laboratory and receive a yes-or-no answer the way they can for an underactive thyroid.

What they can do is measure inflammation. The two standard markers are the erythrocyte sedimentation rate (ESR), a measure of how quickly red blood cells settle in a tube, and C-reactive protein (CRP), a protein the liver releases when inflammation is active. In PMR both are usually raised, and guidance from Mayo Clinic and the NHS lists them as core investigations. They come first for practical reasons: both are run from one ordinary blood draw, results return quickly, and the pattern they show changes what happens next.

Three things hang on those numbers. A clearly raised ESR or CRP in someone with the classic story makes PMR more likely. A normal pair prompts a harder look at alternatives. Whichever way the results fall, they become the baseline against which every later test is compared once treatment starts.

A fourth job gets less attention. The same blood draw usually includes tests for the conditions that mimic PMR: late-onset rheumatoid arthritis, thyroid disease, muscle disorders, infection and some cancers. Inflammation markers are the headline, but the supporting cast matters just as much, because a raised CRP is common to all of these and points to none in particular.

The right way to think of ESR and CRP, then, is less as a verdict and more as a weight placed on one side of a scale the clinician is already balancing. How heavy that weight is depends on everything else in the pan.

What ESR and CRP actually measure, in plain language

Picture a narrow glass tube of blood left standing upright. Red blood cells are heavier than the fluid around them, so they sink. Normally they sink slowly, because each cell carries a slight negative charge that keeps it apart from its neighbors. When inflammation is present, the liver pours out proteins such as fibrinogen, a clotting protein, and these coat the red cells, cancel that repulsion and let the cells clump into stacks. Stacks fall faster than single cells. The erythrocyte sedimentation rate is simply how many millimeters of clear plasma have appeared at the top of the tube after one hour.

That elegance is also the weakness. Anything that changes the cells or the plasma changes the number. Anemia, a shortage of red cells, speeds settling. Pregnancy, older age, kidney disease and some antibody disorders raise ESR without any joint inflammation at all. MedlinePlus describes the test as nonspecific: it says that something is going on without saying what.

CRP works differently. It is a single protein made in the liver in response to a chemical messenger called interleukin-6, which immune cells release when they detect injury or infection. Levels begin to climb within hours of inflammation starting and fall within a day or two of it settling. Because CRP responds to one signal rather than to the physical behavior of blood cells, it is less distorted by age, anemia or pregnancy, though it rises with infection, excess body weight and smoking.

The two tests describe the same fire from different distances. CRP is the smoke detector, quick to trigger and quick to reset. ESR is the scorch mark, slower to appear and slower to fade. Clinicians ask for both because a disagreement between them is itself useful information, and because in a small number of people only one of the two is raised.

How high is ESR in polymyalgia rheumatica?

No single number defines PMR, and anyone offering one is simplifying. Some context helps, though. MedlinePlus gives typical upper limits for healthy adults over 50 of about 20 mm per hour for men and 30 mm per hour for women; younger adults run lower. Laboratories print their own reference ranges on the report, and those are the ranges that matter for your result.

In active, untreated PMR the ESR is commonly well above those limits. Older diagnostic criteria, still quoted in teaching, used a threshold of roughly 40 mm per hour as one supporting feature. Values two or three times the upper limit are not unusual at presentation, and very high readings occur. Current practice has moved away from a strict cut-off, partly because a meaningful minority of people with otherwise typical PMR present with an ESR that is only mildly raised.

Interpreting the number means adjusting for the person. ESR drifts upward with age even in health, which is exactly the age group PMR affects. It also rises with anemia, which PMR itself can cause. A result of 45 in a healthy 40-year-old and the same result in an 80-year-old with mild anemia mean rather different things, and a clinician reads them accordingly.

The far end of the scale carries its own warning. An ESR above 100 mm per hour is seen in PMR, but it should also make a clinician think about giant cell arteritis, serious infection, myeloma (a cancer of antibody-producing cells) and other conditions that need their own tests. High is supportive; extremely high is a prompt to widen the search rather than close it.

The ESR also responds slowly. Someone whose symptoms began two weeks ago may still be climbing toward their peak value, which is one reason a repeat test after a short interval sometimes tells a clearer story than the first.

What is the typical CRP level in polymyalgia rheumatica?

Ask a rheumatologist this question and you will get a careful answer rather than a figure, and the caution is well founded. CRP is reported against a laboratory’s reference range, and while most labs use a similar upper limit for the general adult population, the exact cut-off and units vary. Your report will show your value beside that range, and that comparison is the useful one.

In untreated PMR the CRP is raised in most people, frequently several times the upper limit of normal. Unlike ESR it changes little with age, so an elevation in an older adult carries roughly the same weight as in a younger one. Mild elevations occur, and a small proportion of people have a normal CRP at first testing, which is one reason both markers are requested rather than one.

What CRP cannot do is name the cause. A chest infection, a dental abscess, a flare of gout or a recent fall can push the value into the same territory as PMR. Carrying extra weight and smoking nudge it upward chronically. A clinician reading a raised CRP asks whether there is another explanation before asking whether the result fits PMR.

The pattern over time is more informative than any single reading. CRP typically falls quickly once inflammation is controlled, so a repeat value a few weeks into treatment helps show whether the process is responding. A CRP that stays high despite symptom relief, or that climbs again while a person feels well, prompts a fresh look at what else might be happening, including infection.

So the honest answer to the question is this: usually clearly above the reference range at diagnosis, occasionally only just above it, and always read alongside symptoms, ESR and the other blood results rather than on its own. The number supports a diagnosis; it does not make one.

ESR vs CRP for PMR: which marker matters more?

Neither replaces the other, and the reason becomes clear when the two are set side by side.

Feature	ESR	CRP
What it measures	How fast red cells settle in one hour, driven by inflammatory proteins in plasma	A single liver protein produced in response to interleukin-6
Time to rise	Days	Hours
Time to fall once inflammation settles	Weeks	A day or two
Effect of age	Rises with age; age-adjusted ranges used	Little effect
Distorted by	Anemia, pregnancy, kidney disease, abnormal antibodies	Infection, excess weight, smoking
Typical finding at PMR diagnosis	Usually raised, sometimes markedly	Usually raised, often several-fold
Main role in PMR	Supports diagnosis; catches cases where CRP is normal	Tracks response to treatment; catches cases where ESR is normal

The table explains a common clinical habit: order both at the start, lean on CRP when tracking the response to treatment because it moves faster, and keep watching ESR because it occasionally rises in PMR when CRP does not, and vice versa. When the two disagree, the clinician looks for whatever could be distorting one of them: anemia, kidney disease or an antibody disorder for ESR; a passing infection for CRP.

Guidance from Mayo Clinic and the NHS treats the markers as complementary rather than competing, and neither is used as a pass-or-fail threshold. If either is clearly raised in the right clinical setting, it counts. If both are normal, the diagnosis is questioned rather than dismissed, and a specialist opinion is often sought.

If pressed to choose, most clinicians would say that CRP is the better day-to-day companion during treatment and ESR the more useful historical record. In practice, though, the question is rarely forced. The two tests cost the body nothing extra, since both come from the same vial, and the information they give together is worth more than either alone.

What other bloodwork is abnormal in polymyalgia rheumatica?

ESR and CRP get the attention, but the rest of the panel does quieter and equally necessary work. Some of it looks for PMR’s own footprints; most of it looks for imitators.

A full blood count often shows a mild anemia of the type that accompanies chronic inflammation, with red cells of normal size but reduced in number. Platelets, the small cells involved in clotting, are frequently raised for the same reason. Liver tests may show a modest rise in alkaline phosphatase, an enzyme that can climb during inflammation; the other liver values are usually normal. Creatine kinase (CK), an enzyme released from damaged muscle, is characteristically normal in PMR. That matters, because a raised CK suggests a true muscle disease such as polymyositis, or a medication-related muscle injury, both of which can feel similar from the inside.

Then come the exclusion tests. Thyroid function is checked because an underactive thyroid causes aches, stiffness and fatigue. Rheumatoid factor and anti-CCP antibodies, two markers of rheumatoid arthritis, are usually negative in PMR; a positive result raises the possibility of late-onset rheumatoid arthritis, which can begin in the shoulders. Calcium, kidney function and protein electrophoresis (a test that separates blood proteins to spot an abnormal antibody) screen for myeloma, which can cause bone pain and a very high ESR in the same age group. A urine test looks for blood or protein that might point elsewhere.

Finally there are tests that have nothing to do with diagnosis and everything to do with what comes next. Blood glucose or HbA1c, vitamin D and a bone profile are often checked because glucocorticoids, the class of medicine usually used for PMR, can raise blood sugar and weaken bone over time. Those baselines let the team watch for problems rather than discover them late. Which tests appear on your form is a decision for your clinician, guided by your history and examination.

Why blood tests support a PMR diagnosis rather than prove it

The word ‘confirm’ deserves scrutiny, because it is not quite how clinicians think. PMR is a clinical diagnosis: a pattern of symptoms in the right age group, a compatible examination, supportive blood results and, crucially, the absence of a better explanation. Blood tests contribute to two of those four legs.

The list of conditions that can look like PMR is long, and several of them also raise ESR and CRP. Late-onset rheumatoid arthritis can begin with stiff, painful shoulders before the hands are involved. Giant cell arteritis, inflammation of the medium and large arteries that shares PMR’s age group and often coexists with it, produces the same blood picture with far higher stakes. Infections, including those smoldering in a heart valve or the spine, can present with aches, fatigue and inflammation. Some cancers, particularly blood cancers, do the same. On the other side sit conditions that mimic the symptoms without raising the markers: fibromyalgia, osteoarthritis of both shoulders, rotator cuff disease, an underactive thyroid, and muscle aches from statin medicines.

A raised CRP is therefore the beginning of a conversation. Mayo Clinic notes that imaging, usually ultrasound of the shoulders and hips, may be added to look for inflammation of the bursae and tendon sheaths that is typical of PMR and less typical of its imitators. Referral to a rheumatologist is commonly advised when the picture is atypical, when markers are normal, when the person is younger than usual, or when the response to treatment is incomplete.

The rapid improvement most people experience once treatment begins is itself treated as supporting evidence. If the expected response does not arrive, Mayo Clinic and NHS guidance recommend that the diagnosis be revisited rather than the treatment simply escalated. In that sense the process of confirming PMR continues for weeks after the first blood draw, and the laboratory is only one voice in it.

Can you have polymyalgia rheumatica with normal blood tests?

Yes, though it is the exception, and the answer needs careful handling because it is misused in both directions.

Most people with active PMR have a raised ESR, a raised CRP, or both. A minority present with normal values for one marker, and a smaller number have both within range at the first test. Case series describing these people exist in the rheumatology literature, and mainstream guidance acknowledges the possibility without offering a single reliable figure, partly because the definition of normal shifts with age and laboratory.

Several things can produce a normal result in real PMR. The person may be tested early, before the ESR has had time to climb. They may have taken an anti-inflammatory or a short course of a steroid for another reason, damping the markers. Their laboratory’s reference range may be generous for their age. Or they may simply be among those whose disease runs with unusually low measurable inflammation.

What follows from a normal pair is not dismissal but caution. Clinicians are generally advised to look harder at the alternatives that do not raise inflammation markers, such as osteoarthritis, rotator cuff problems, fibromyalgia and thyroid disease, to consider ultrasound of the shoulders and hips, and to seek a specialist opinion before treating on symptoms alone. A repeat test after a couple of weeks, if symptoms allow the wait, sometimes resolves the uncertainty.

The reverse misuse is just as common. Online forums sometimes carry the claim that normal bloods mean a doctor must still diagnose PMR if the symptoms fit. That is not how guidance reads. Normal markers lower the probability of PMR and raise the importance of excluding other causes; they do not eliminate the diagnosis, and they do not confirm it either. The person who fits this picture is exactly the one who benefits most from a rheumatologist’s involvement, and from patience with a process that may take more than one visit.

Who is usually tested for PMR, and who is usually asked to wait

The blood tests are requested when the story fits. NHS and Mayo Clinic guidance describes the core picture: age over 50, with most people in their seventies at onset; pain and stiffness affecting both shoulders and often both hips; symptoms worst on waking and after rest, with morning stiffness lasting well beyond a few minutes; and difficulty with everyday reaching, such as dressing or rising from a chair. Fatigue, low mood, mild fever, poor appetite and weight loss sometimes accompany the aches. Women are affected more often than men, and the condition is more common in people of northern European ancestry.

Someone with that pattern is generally tested promptly. No one with red-flag features for giant cell arteritis, described later in this article, should wait for anything.

Others are usually asked to hold on, not because their symptoms are doubted but because testing too early gives muddy answers. A person whose stiffness began three days ago may be at the start of a viral illness that will settle on its own; guidance commonly looks for symptoms that have persisted for a couple of weeks before PMR is seriously considered. Someone recovering from a chest infection or a recent operation will have a raised CRP for that reason alone, so testing during recovery cannot separate the two. A person who has just finished a course of steroid tablets for another condition will have artificially low markers.

Age matters too. PMR under 50 is rare enough that a younger person with identical symptoms is more likely to have something else, and clinicians will usually pursue those alternatives first rather than order PMR-focused tests.

Waiting, in these cases, is not neglect. It is a way of making sure that when the sample is finally drawn, the result means what it appears to mean. The judgment about timing belongs to the treating clinician, who can weigh the discomfort of a short delay against the cost of a misleading number, and who can reconsider if symptoms change.

Polymyalgia rheumatica blood tests before treatment: why the baseline matters

The word ‘before’ in this article’s title is doing important work. PMR is usually treated with a glucocorticoid, a class of anti-inflammatory steroid medicine that suppresses the immune signals driving the inflammation. That suppression is the point of the treatment, and it is also why the timing of blood tests matters so much.

Glucocorticoids lower CRP within days and ESR within weeks. Draw the blood after treatment has begun and the markers may already be drifting toward normal, leaving the clinician unable to tell whether they were ever raised. The same problem affects the mimics: a raised CK from a muscle disease or a positive rheumatoid factor will not disappear, but the overall inflammatory picture that helps weigh them will be blurred. Once treatment is under way, a normal CRP could mean the disease is controlled or that it was never inflammatory, and there is no way to tell which.

The pre-treatment sample also sets the yardstick. Later results are interpreted against that starting point, not against the population range alone. A person whose CRP began ten times above normal and is now twice above normal has responded substantially; the same value in someone who started only slightly raised tells a different story.

Then there is safety. Glucocorticoids can raise blood sugar, increase blood pressure, thin bones and, with longer use, affect the eyes and skin. NHS guidance notes that treatment for PMR typically continues for one to two years. Knowing the glucose, bone profile and vitamin D before the medicine starts lets the team watch for these effects and act early. A baseline blood pressure and a discussion about bone protection usually happen at the same visit.

None of this means a person in severe pain must suffer while awaiting a laboratory slot. In practice the blood draw and the prescription often happen on the same day, with the sample taken first. Where steroids have already been started elsewhere, the clinician works with what is available and interprets accordingly. The sequencing decision, like every other, rests with the treating team.

What the following days and weeks usually look like

Results from a routine ESR, CRP and blood count are usually available within a few days, sometimes the same day, depending on the laboratory. The clinician reviews them alongside the story and, if the pattern fits and nothing points elsewhere, discusses treatment. If the pattern does not fit, the next step is more often a referral or further tests than a prescription.

For those who begin glucocorticoid treatment, the first week is often striking. Mayo Clinic and NHS guidance both describe improvement in pain and stiffness within a few days, with a marked response expected within a week or two. That speed is diagnostic in itself. A slow or partial response is one of the main reasons a diagnosis is reconsidered, and both sources advise reporting it rather than assuming more time is needed.

Blood tests are repeated at intervals the clinician chooses, commonly a few weeks after starting and then periodically through the course. CRP falls quickly as inflammation is controlled; ESR lags, sometimes by several weeks, so an ESR still above range at the first follow-up while symptoms have resolved is not by itself a cause for concern. Over the following months the aim is to keep symptoms controlled while the medicine is gradually reduced, guided by how the person feels and by the markers together. Flares, in which symptoms and markers rise again as the medicine is reduced, are common and are managed by the prescribing clinician. NHS guidance describes typical treatment courses of one to two years, with some people needing longer.

Glucose and bone health are monitored alongside the inflammation markers because of the medicine’s effects, and blood pressure and weight are usually checked at reviews. Many people find it helpful to keep a simple diary of how long morning stiffness lasts, since that one measure often tracks the disease more faithfully than any number on a report, and gives the care team something concrete to weigh against the laboratory.

What people often get wrong about ESR, CRP and PMR

A high ESR means PMR. It does not. Dozens of conditions raise ESR, and in an older adult the list includes infection, myeloma, giant cell arteritis and rheumatoid arthritis. The test supports a diagnosis that already fits; it never makes one on its own.

Normal markers rule PMR out. Not quite. A minority of people with PMR have a normal ESR or CRP at first testing. What normal results do is lower the likelihood and raise the priority of looking for something else, which is why specialist review is usually advised in that situation.

The CRP number tells you how bad the disease is. Only loosely. Two people with the same CRP can have very different symptoms, and a person can feel dreadful with a modest value. Clinicians treat the person, using the number as one input rather than a severity score.

It is fine to start the medicine and test later. Testing after treatment has begun can erase the evidence. Glucocorticoids pull CRP down within days, so a later normal result cannot show whether inflammation was ever present. When tests and treatment happen on the same day, the sample comes first.

Markers must be normal before I can feel well. The reverse is usually true: symptoms improve before ESR normalizes, because ESR falls slowly. A lingering mild elevation in someone who feels well is common and is not a reason for alarm or for changing anything without the prescriber’s input.

PMR is a muscle disease. Despite the name, which translates roughly as ‘many muscle pains’, the inflammation sits in the joint linings, bursae and tendon sheaths around the shoulders and hips. Muscles are not damaged, which is why the muscle enzyme CK is normal. A raised CK points away from PMR, not toward it.

Online stories replace a clinician’s reading. Forum accounts of unusual results are real experiences, but they describe individuals. Your own result is best interpreted by someone who can see your history, your examination and your laboratory’s ranges together.

Questions to ask your care team

A short list, brought to the appointment, turns a rushed results conversation into a useful one. These are the questions that most often lead somewhere.

• Were my ESR and CRP raised, and by how much compared with the range for my age and sex?
• Which other blood tests did you order, and were any of them abnormal? Did anything point toward a condition other than PMR?
• Was my creatine kinase normal, and were rheumatoid factor and anti-CCP checked?
• Did you screen for myeloma and thyroid disease, and were those results reassuring?
• Were the samples taken before any steroid medicine, and if not, how does that affect how you read them?
• Do I need an ultrasound of my shoulders or hips, or a referral to a rheumatologist, and what would that add?
• What symptoms would make you think this is giant cell arteritis rather than PMR alone, and what should I do if they appear?
• How quickly should I expect to feel better once treatment begins, and what should I do if I do not?
• When will my blood tests be repeated, and which results will you be watching?
• What baseline checks for blood sugar, blood pressure and bone health were done, and how will those be followed?
• Who do I contact between appointments if symptoms return or new ones appear?

Bring a note of when your symptoms began, how long your morning stiffness lasts, and any medicines you have taken in the past few weeks, including over-the-counter anti-inflammatories and any steroid course for another problem. Those details change how the numbers are read.

Ask, too, for a copy of the results or access to them through your patient record. Having the actual figures, with the laboratory’s ranges beside them, makes every future conversation easier and lets you see the trend for yourself rather than relying on memory.

When to call your doctor: polymyalgia rheumatica red flags

The most important red flags in PMR are not about PMR at all. They concern giant cell arteritis (GCA), a condition in which the walls of medium and large arteries, often those supplying the scalp and eyes, become inflamed. GCA shares PMR’s age group, frequently occurs alongside it, and can cause permanent sight loss if not treated urgently. NHS guidance advises seeking care the same day if any of the following appear, whether or not a diagnosis of PMR has already been made:

• A new, persistent headache, often around the temples, in someone who does not usually get headaches
• Tenderness of the scalp, noticed when brushing hair or resting the head on a pillow
• Pain or tiredness in the jaw muscles when chewing, which eases with rest
• Any change in vision: blurring, double vision, a curtain across part of the visual field, or sudden loss of sight in one eye, even briefly
• Unexplained fever, drenching night sweats or rapid weight loss

Sudden visual symptoms warrant emergency care, not a routine appointment.

Other situations deserve a prompt call rather than a wait for the next review. If you have started glucocorticoid treatment and your pain and stiffness have not clearly improved within a week or two, tell the prescriber; guidance treats that as a reason to reconsider the diagnosis. If symptoms return sharply after improving, or spread to new joints, particularly the hands and wrists, say so, since that can signal a flare or a different form of arthritis. Because glucocorticoids dampen the immune system, a fever, a productive cough, burning on passing urine, or a wound that will not settle should be reported rather than waited out.

Severe pain, weakness that makes climbing stairs or lifting the arms impossible, or a fall are also reasons to make contact. Never stop, start or change a prescribed medicine on the strength of a blood result or a symptom without speaking to the person who prescribed it; sudden changes to glucocorticoids carry their own risks, and your team can advise safely.

Frequently asked questions

What is the typical CRP level in polymyalgia rheumatica?

There is no fixed value; in untreated PMR the CRP is usually clearly above the laboratory’s reference range, often several times the upper limit, though some people have only a mild rise and a few have a normal result. CRP changes little with age, so an elevation in an older adult is read at face value. The trend over time, compared with your own pre-treatment baseline, tells clinicians more than any single number.

How high is ESR in polymyalgia rheumatica?

Usually well above the age-adjusted upper limit, which MedlinePlus puts at roughly 20 mm per hour for men and 30 for women over 50. Older diagnostic criteria used about 40 mm per hour as a supporting feature, and values two or three times the upper limit are common at presentation. Current practice avoids a strict cut-off because a minority of people with PMR have only a mildly raised ESR.

What is the red flag for polymyalgia rheumatica?

The key red flags point to giant cell arteritis, which often accompanies PMR and can threaten sight. NHS guidance lists a new persistent headache, scalp tenderness, jaw pain when chewing, and any change in vision, including brief loss of sight in one eye. These need same-day assessment, and sudden visual symptoms need emergency care. Fever, night sweats and rapid weight loss also warrant prompt review.

What bloodwork is abnormal in polymyalgia rheumatica?

Raised ESR and CRP are the main findings. A full blood count often shows mild anemia of chronic inflammation and raised platelets, and alkaline phosphatase, a liver enzyme, may be modestly elevated. Creatine kinase is normal, and rheumatoid factor and anti-CCP antibodies are usually negative. Thyroid, calcium, kidney tests and protein electrophoresis are typically normal and are ordered to exclude conditions that mimic PMR.

Can you be diagnosed with polymyalgia rheumatica with normal blood tests?

It is possible but uncommon. A small number of people with genuine PMR have a normal ESR, CRP or both at first testing, sometimes because they were tested early or had recently taken an anti-inflammatory or steroid. Normal results lower the likelihood of PMR and increase the importance of excluding other causes, so guidance generally advises specialist review and sometimes ultrasound before treating on symptoms alone.

Should ESR and CRP be checked before starting steroids?

Yes, wherever practical. Glucocorticoids lower CRP within days and ESR within weeks, so a sample drawn after treatment has begun cannot show whether inflammation was ever present or how high it was. The pre-treatment result also becomes the baseline for judging response. If steroids have already been started elsewhere, your clinician will interpret later results with that in mind rather than repeat the process.

Do I need to fast before ESR and CRP tests?

No fasting is needed for ESR or CRP themselves. If your clinician has added blood glucose or a lipid profile to the same draw, they may ask you to fast beforehand, so check the instructions on your request form. Tell the person taking the sample about any recent infection, steroid course or anti-inflammatory use, because these can shift the results and affect how they are read.

How often are ESR and CRP repeated in PMR?

Intervals are set by your clinician, but a common pattern is a repeat a few weeks after treatment begins, then periodic checks through a course that NHS guidance describes as typically lasting one to two years. Tests are also repeated if symptoms return during dose reduction or if new symptoms appear. CRP is the more responsive marker for tracking, while ESR may lag several weeks behind how you feel.

Does a very high ESR mean my PMR is severe?

Not necessarily. ESR reflects the amount of inflammatory protein in the blood, not how much pain or disability a person has, and two people with the same value can feel very different. A very high reading, particularly above 100 mm per hour, is more important as a prompt for clinicians to consider giant cell arteritis, infection or myeloma alongside PMR than as a measure of severity.

Can a raised CRP be caused by something other than PMR?

Yes, frequently. CRP rises with any significant inflammation: chest or urinary infections, dental abscesses, gout flares, injury, surgery and many autoimmune conditions. Excess body weight and smoking raise it chronically by smaller amounts. Because it cannot identify the source, clinicians read a raised CRP alongside symptoms, examination and the other blood tests, and they ask about recent illness before attributing it to PMR.

References

• NHS: Polymyalgia rheumatica
• NHS: Giant cell arteritis (temporal arteritis)
• MedlinePlus: Erythrocyte sedimentation rate (ESR)
• MedlinePlus: C-reactive protein (CRP) test

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.